Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03303365 : Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- radiologically confirmed metastases of the brain with an underlying history of a
malignant illness

- between one and ten suspect intracranial lesions, taking into consideration all
available series of the pre-therapeutic MRI (performed at Heidelberg University
Hospital and including SPACE sequence)

- age = 18 years of age

- Karnofsky Performance Score (KPS) = 70

- for women with childbearing potential, (and men) adequate contraception.

- ability to understand character and individual consequences of the clinical trial

- written informed consent (must be available before enrolment in the trial)

Exclusion Criteria:

- refusal of the patient to take part in the study

- Small-cell lung cancer (SCLC) as primary malignant illness

- More than 10 suspect intracranial lesions in the initial pre-therapeutic MRI imaging
(performed at Heidelberg University Hospital and including SPACE sequence)

- metastasis so close to OAR that initial single-session SRS would be impossible due to
lacking radiotolerance

- known contraindications against the performing of cranial MRI

- previous radiotherapy of the brain

- Patients who have not yet recovered from acute toxicities of prior therapies

- Pregnant or lactating women

- Participation in another clinical study or observation period of competing trials,
respectively
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03303365      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740